Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Algeta and Sanofi extend research collaboration

April 30, 2012

Novel telomerase inhibitors developed at Pharminox

April 30, 2012

BioAlliance Pharma provides update on AMEP biotherapy

April 30, 2012

Novel PLK1 inhibitor exhibits antitumor activity in vivo

April 30, 2012

FDA approves sNDA for Votrient

April 30, 2012

Investigation at Bionature yields novel candidate oncolytics

April 27, 2012

Novartis extends oncology discovery research collaboration

April 27, 2012

Phase I trial tests once-daily and intermittent INK-128 dosing

April 27, 2012

Epizyme forms strategic partnership with Celgene

April 27, 2012

Phase I trial studies vandetanib combination therapy for brain cancer

April 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...